201 related articles for article (PubMed ID: 9891023)
1. Generation of artificial proteoglycans containing glycosaminoglycan-modified CD44. Demonstration of the interaction between rantes and chondroitin sulfate.
Wolff EA; Greenfield B; Taub DD; Murphy WJ; Bennett KL; Aruffo A
J Biol Chem; 1999 Jan; 274(4):2518-24. PubMed ID: 9891023
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the heparan sulfate and chondroitin sulfate assembly sites in CD44.
Greenfield B; Wang WC; Marquardt H; Piepkorn M; Wolff EA; Aruffo A; Bennett KL
J Biol Chem; 1999 Jan; 274(4):2511-7. PubMed ID: 9891022
[TBL] [Abstract][Full Text] [Related]
3. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
Jackson DG; Bell JI; Dickinson R; Timans J; Shields J; Whittle N
J Cell Biol; 1995 Feb; 128(4):673-85. PubMed ID: 7532175
[TBL] [Abstract][Full Text] [Related]
4. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.
Kawashima H; Hirose M; Hirose J; Nagakubo D; Plaas AH; Miyasaka M
J Biol Chem; 2000 Nov; 275(45):35448-56. PubMed ID: 10950950
[TBL] [Abstract][Full Text] [Related]
5. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.
Bennett KL; Jackson DG; Simon JC; Tanczos E; Peach R; Modrell B; Stamenkovic I; Plowman G; Aruffo A
J Cell Biol; 1995 Feb; 128(4):687-98. PubMed ID: 7532176
[TBL] [Abstract][Full Text] [Related]
6. Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44.
Guo JY; Chiu CH; Wang MJ; Li FA; Chen JY
J Biomed Sci; 2020 Jan; 27(1):2. PubMed ID: 31898491
[TBL] [Abstract][Full Text] [Related]
7. Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells.
Toyama-Sorimachi N; Kitamura F; Habuchi H; Tobita Y; Kimata K; Miyasaka M
J Biol Chem; 1997 Oct; 272(42):26714-9. PubMed ID: 9334256
[TBL] [Abstract][Full Text] [Related]
8. Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney.
Steer DL; Shah MM; Bush KT; Stuart RO; Sampogna RV; Meyer TN; Schwesinger C; Bai X; Esko JD; Nigam SK
Dev Biol; 2004 Aug; 272(2):310-27. PubMed ID: 15282150
[TBL] [Abstract][Full Text] [Related]
9. Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor.
Deepa SS; Yamada S; Zako M; Goldberger O; Sugahara K
J Biol Chem; 2004 Sep; 279(36):37368-76. PubMed ID: 15226297
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action.
Jones M; Tussey L; Athanasou N; Jackson DG
J Biol Chem; 2000 Mar; 275(11):7964-74. PubMed ID: 10713114
[TBL] [Abstract][Full Text] [Related]
11. Effect of transforming growth factor-beta 1 and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts. Enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypican.
Romarís M; Bassols A; David G
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):73-81. PubMed ID: 7544118
[TBL] [Abstract][Full Text] [Related]
12. Characterization of ryudocan glycosaminoglycan acceptor sites.
Shworak NW; Shirakawa M; Mulligan RC; Rosenberg RD
J Biol Chem; 1994 Aug; 269(33):21204-14. PubMed ID: 7520439
[TBL] [Abstract][Full Text] [Related]
13. Chondroitin sulphate composition and structure in alternatively spliced CD44 fusion proteins.
Piepkorn M; Hovingh P; Bennett KL; Aruffo A; Linker A
Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):499-506. PubMed ID: 9359422
[TBL] [Abstract][Full Text] [Related]
14. RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement.
Roscic-Mrkic B; Fischer M; Leemann C; Manrique A; Gordon CJ; Moore JP; Proudfoot AE; Trkola A
Blood; 2003 Aug; 102(4):1169-77. PubMed ID: 12714503
[TBL] [Abstract][Full Text] [Related]
15. Site-specific identification of heparan and chondroitin sulfate glycosaminoglycans in hybrid proteoglycans.
Noborn F; Gomez Toledo A; Green A; Nasir W; Sihlbom C; Nilsson J; Larson G
Sci Rep; 2016 Oct; 6():34537. PubMed ID: 27694851
[TBL] [Abstract][Full Text] [Related]
16. Colocalization of basic fibroblast growth factor and CD44 isoforms containing the variably spliced exon v3 (CD44v3) in normal skin and in epidermal skin cancers.
Grimme HU; Termeer CC; Bennett KL; Weiss JM; Schöpf E; Aruffo A; Simon JC
Br J Dermatol; 1999 Nov; 141(5):824-32. PubMed ID: 10583162
[TBL] [Abstract][Full Text] [Related]
17. Analysis of CD44 interactions with hyaluronan in murine L cell fibroblasts deficient in glycosaminoglycan synthesis: a role for chondroitin sulfate.
Esford LE; Maiti A; Bader SA; Tufaro F; Johnson P
J Cell Sci; 1998 Apr; 111 ( Pt 7)():1021-9. PubMed ID: 9490645
[TBL] [Abstract][Full Text] [Related]
18. CD44 binds a chondroitin sulfate proteoglycan, aggrecan.
Fujimoto T; Kawashima H; Tanaka T; Hirose M; Toyama-Sorimachi N; Matsuzawa Y; Miyasaka M
Int Immunol; 2001 Mar; 13(3):359-66. PubMed ID: 11222505
[TBL] [Abstract][Full Text] [Related]
19. Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: assessment of selectivity, heterogeneity and the participation of core proteins in binding.
Herndon ME; Stipp CS; Lander AD
Glycobiology; 1999 Feb; 9(2):143-55. PubMed ID: 9949192
[TBL] [Abstract][Full Text] [Related]
20. Chondroitin sulfate and heparan sulfate-containing proteoglycans are both partners and targets of basic fibroblast growth factor-mediated proliferation in human metastatic melanoma cell lines.
Nikitovic D; Assouti M; Sifaki M; Katonis P; Krasagakis K; Karamanos NK; Tzanakakis GN
Int J Biochem Cell Biol; 2008; 40(1):72-83. PubMed ID: 17706452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
